Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
amgen
boston blog main
clinical trials
fda
national top stories
new york
new york blog main
new york top stories
san francisco blog main
sanofi
akili interactive labs
biotech
boston top stories
bruce leuchter
calcitonin gene-related peptide
cholesterol
chronic migraine
click therapeutics
clickotine
data
david benshoof klein
david klein
digital health
digital medicines
digital therapeutics
drugs
eli lilly
episodic migraine
inclisiran
indiana
indiana blog main
indiana top stories
joshua steinerman
ldl
mark timney
migraine
mt sinai hospital
pcsk9
What
announced
3
×
drug
3
×
medicines
3
×
medicine
aces
approval
approved
backs
bets
big
ceo
cholesterol
class
click
decision
developed
digital
eli
example
fda
field
flexible
gain
grabbed
headache
inclisiran
key
late
latest
lilly
lowering
makers
making
marks
meant
medco
migraine
momentum
monday
nascent
Language
unset
Current search:
medicines
×
drug
×
announced
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
